Researchers Explain Why COVID-19 Variants Like Omicron Evade Immune Defenses and Suggest new Strategies for Building Longer-Lasting Antibody Therapies and Vaccines
RT’s Three Key Takeaways:
- Extensive Antibody Mapping – Mount Sinai researchers created the moast complete structural atlas of SARS-CoV-2 antibodies to date, revealing exactly how antibodies attach to the spike protein and how viral mutations weaken that binding.
- Convergent Vulnerabilities & immune Escape – Analysis of more than 1,000 antibody-spike structures shows that most antibodies bind in only a few structurally similar ways, helping explain why variants like Omicron can escape nearly all existing antibodies.
- Path to Next-Generation Therapies – Findings highlight the promise of multi-site-targeting antibodies and nanobodies, offering new strategic directions for designing longer-lasting antiviral treatments and vaccines resistant to viral evolution.
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations weaken that attachment. The findings, published in Cell Systems, explain why variants like Omicron can evade immune defenses and suggest new strategies for building longer-lasting antibody therapies and vaccines.
The team analyzed more than a thousand three-dimensional structures of antibodies bound to the virus’s spike protein, the main target for immune recognition. This detailed analysis reveals how antibodies neutralize the virus and, crucially, how mutations in the spike protein allow the virus to escape antibody neutralization.
Worth a look